Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens

Cervical cancer screening programs rely on accurate human papillomavirus (HPV) testing to identify high-risk infections. Traditional methods depend on clinician-collected cervical specimens, which may limit participation due to access or comfort barriers. While self-collection methods have shown promise, their diagnostic accuracy compared to clinician-collected samples remains under investigation. Prior research has shown that self-collected samples can be viable for HPV testing, but evidence on agreement rates for specific HPV types is limited. No prior work had resolved the impact of collection setting—clinic versus at-home—on test accuracy. This gap motivated further evaluation of self-collection as a scalable screening option. Researchers wanted to determine whether self-collected vaginal samples could reliably replace cervical samples for HPV16, HPV18, and other high-risk types. They also aimed to assess the stability of self-collected samples under extreme conditions. These factors are essential for implementing self-collection in public health programs.

This study aimed to evaluate the diagnostic accuracy of self-collected vaginal specimens compared to clinician-collected cervical specimens for HPV testing. Researchers focused on three key HPV types: HPV16, HPV18, and high-risk other (HRO) HPV. The goal was to determine whether self-collection could serve as a reliable alternative in cervical cancer screening. The study also sought to compare in-clinic and at-home self-collection methods. Researchers wanted to assess the impact of collection setting on test agreement. They aimed to measure total, positive, and negative percentage agreement for each HPV type. Another objective was to evaluate sample stability under extreme temperatures. These findings would inform the feasibility of expanding self-collection as a screening option.

The study used a diagnostic accuracy design to compare HPV test results from self-collected and clinician-collected specimens. Two participant cohorts were enrolled: one collected vaginal samples in the clinic before a cervical sample, and the other collected at home and mailed the sample. Specimens were tested for HPV16, HPV18, and HRO HPV using standard PCR-based methods. Agreement was measured using total, positive, and negative percentage agreement. Researchers also conducted temperature stability tests on stored samples. Data were analyzed to compare in-clinic and at-home self-collection performance. The study included 79 in-clinic and 115 at-home participants. All specimens were processed and tested in a blinded manner to avoid bias.

In-clinic self-collected vaginal specimens showed strong agreement with clinician-collected cervical samples for HPV16, with 98% total agreement, 100% positive agreement, and 97% negative agreement. For HPV18, the agreement was 99% total, 100% positive, and 99% negative. For HRO HPV, the values were 86% total, 94% positive, and 79% negative. At-home self-collected specimens had 94% total agreement for HPV16, 79% positive agreement, and 96% negative agreement. For HPV18, the agreement was 95% total, 43% positive, and 98% negative. HRO HPV showed 89% total, 80% positive, and 93% negative agreement. Vaginal specimens remained stable under extreme temperatures. These results suggest that in-clinic self-collection is highly accurate for all HPV types. At-home self-collection showed lower positive agreement for HPV18.

The study supports the use of in-clinic self-collected vaginal specimens as a reliable alternative to clinician-collected cervical samples for HPV testing. The high agreement rates for HPV16 and HRO HPV suggest strong diagnostic accuracy. However, the lower positive agreement for HPV18 in at-home self-collected samples indicates a limitation. Researchers propose that in-clinic self-collection is more consistent than at-home methods for certain HPV types. The stability of vaginal specimens under extreme temperatures supports their use in various settings. These findings suggest that self-collection could expand access to cervical cancer screening. The authors recommend further research to optimize at-home collection protocols. They emphasize the importance of validating self-collection in diverse populations.